
SI-BONE rose 63.3% from $15.68 to a 1-year high of $25.60, ahead of the S&P 500's +10.5%. Its worst day was Jan 12 (−12.6%), and its low came May 11 at $11.61.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.11 beat the $-0.16 estimate on $48.7M revenue (est. $46.7M); FY revenue guidance of $198.0M–$200.0M against the $196.7M consensus.
+16.2% · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
SI-BONE shares fell 12.6%, while the S&P 500 rose 0.2%.
−12.6%, the year's worst day · S&P 500 +0.2%
EPS of $-0.04 beat the $-0.13 estimate on $56.4M revenue (est. $56.3M); FY revenue guidance of $228.5M–$232.5M against the $229.9M consensus.
−2.1% · S&P 500 +0.7%
SI-BONE shares rose 9.0%, while the S&P 500 rose 1.0%.
+9.0% · S&P 500 +1.0%
EPS of $-0.10 beat the $-0.19 estimate on $52.6M revenue (est. $51.2M); FY revenue guidance of $230.0M–$233.0M against the $230.5M consensus.
+19.7%, the year's best day, on 3M shares, the year's heaviest volume · S&P 500 −0.2%
EPS of $-0.09 beat the $-0.15 estimate on $56.0M revenue (est. $55.2M); FY revenue guidance of $231.0M–$233.0M against the $231.6M consensus.
−0.1% · S&P 500 +1.8%
SI-BONE shares rose 9.6%, while the S&P 500 rose 0.7%.
+9.6% · S&P 500 +0.7%
EPS of $-0.08 beat the $-0.13 estimate on $55.7M revenue (est. $55.3M); FY revenue guidance of $231.0M–$233.0M against the $232.2M consensus.
+17.6% · S&P 500 +0.3%
Where it ended: a 1-year high close of $25.60 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 22, 2027 (EPS est. $-0.07, revenue est. $63.1M).
Nothing in the past 12 months.
All SIBN dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SIBN and SPY from Benzinga historical bars. Not investment advice.